Value of serum free prostate-specific antigen density in the diagnosis of prostate cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Value of serum free prostate-specific antigen density in the diagnosis of prostate cancer ; day:6 ; month:7 ; year:2023 ; pages:1-7
Irish journal of medical science ; (6.7.2023), 1-7
- Urheber
-
Zou, Bing-Zi
Wen, Hong
Luo, Huan-Jia
Luo, Wan-Chao
Xie, Qi-Tong
Zhou, Meng-Ting
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11845-023-03448-w
- URN
-
urn:nbn:de:101:1-2023100508575322418397
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zou, Bing-Zi
- Wen, Hong
- Luo, Huan-Jia
- Luo, Wan-Chao
- Xie, Qi-Tong
- Zhou, Meng-Ting
- SpringerLink (Online service)
Ähnliche Objekte (12)
The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity
Prostate-Specific Antigen Density: A Measurement to Differentiate Benign Hypertrophy of Prostate from Prostate Carcinoma
Biomarkers for prostate cancer: prostate-specific antigen and beyond
Utility of Prostate-Specific Antigen Isoforms and Prostate Health Index in the Diagnosis of Metastatic Prostate Cancer
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy
Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy
Prostate-specific antigen testing patterns and prostate cancer stage at diagnosis in older Ohio cancer patients
Prostate-specific antigen-based screening: controversy and guidelines
Prostate-specific antigen testing accuracy in community practice
Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
Prostate cancer risk prediction based on clinical factors and prostate-specific antigen
Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria
The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity
Prostate-Specific Antigen Density: A Measurement to Differentiate Benign Hypertrophy of Prostate from Prostate Carcinoma
Biomarkers for prostate cancer: prostate-specific antigen and beyond
Utility of Prostate-Specific Antigen Isoforms and Prostate Health Index in the Diagnosis of Metastatic Prostate Cancer
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy
Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy
Prostate-specific antigen testing patterns and prostate cancer stage at diagnosis in older Ohio cancer patients
Prostate-specific antigen-based screening: controversy and guidelines
Prostate-specific antigen testing accuracy in community practice
Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
Prostate cancer risk prediction based on clinical factors and prostate-specific antigen
Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria
The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity
Prostate-Specific Antigen Density: A Measurement to Differentiate Benign Hypertrophy of Prostate from Prostate Carcinoma
Biomarkers for prostate cancer: prostate-specific antigen and beyond
Utility of Prostate-Specific Antigen Isoforms and Prostate Health Index in the Diagnosis of Metastatic Prostate Cancer
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy
Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy
Prostate-specific antigen testing patterns and prostate cancer stage at diagnosis in older Ohio cancer patients
Prostate-specific antigen-based screening: controversy and guidelines
Prostate-specific antigen testing accuracy in community practice
Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
Prostate cancer risk prediction based on clinical factors and prostate-specific antigen